Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|October 28, 2021
Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritisMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
Rheumatology Advances in Practice|May 20, 2021
A mixed method study exploring patient satisfaction and feasibility of two exercise programmes in systemic sclerosis-associated microstomiaEllinor Sydow, Kristien Van der Elst, Patrick Verschueren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 3, 2012
Detection of antinuclear antibodies by automated indirect immunofluorescence analysisXavier Bossuyt, Sarah Cooreman, Heidi De Baere, et al.
Seminars in Arthritis and Rheumatism|May 30, 2024
Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidenceMichaël Doumen, Lotte Diricks, Joppe Hermans, et al.
Autoimmunity Reviews|March 6, 2012
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosisKatrijn Op De Beéck, Pieter Vermeersch, Patrick Verschueren, et al.
Rheumatology (Oxford, England)|June 5, 2012
Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNAKatrijn Op De Beéck, Pieter Vermeersch, Patrick Verschueren, et al.
Autoimmunity Reviews|July 12, 2011
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assayKatrijn Op De Beeck, Pieter Vermeersch, Patrick Verschueren, et al.
Annals of the Rheumatic Diseases|January 25, 2018
Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritisLieve Van Hoovels, Julie Jacobs, Bert Vander Cruyssen, et al.
Rheumatology Advances in Practice|February 22, 2020
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologistDiederik De Cock, Kristien Van der Elst, Veerle Stouten, et al.
Patient Education and Counseling|December 9, 2014
Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritisSabrina Meyfroidt, Kristien Van der Elst, Diederik De Cock, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|October 28, 2021
Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritisMichaël Doumen, Diederik De Cock, Sofia Pazmino, et al.
Rheumatology Advances in Practice|May 20, 2021
A mixed method study exploring patient satisfaction and feasibility of two exercise programmes in systemic sclerosis-associated microstomiaEllinor Sydow, Kristien Van der Elst, Patrick Verschueren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 3, 2012
Detection of antinuclear antibodies by automated indirect immunofluorescence analysisXavier Bossuyt, Sarah Cooreman, Heidi De Baere, et al.
Seminars in Arthritis and Rheumatism|May 30, 2024
Definitions of rheumatoid arthritis flare and how they relate to patients' perspectives: A scoping review of qualitative and quantitative evidenceMichaël Doumen, Lotte Diricks, Joppe Hermans, et al.
Autoimmunity Reviews|March 6, 2012
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosisKatrijn Op De Beéck, Pieter Vermeersch, Patrick Verschueren, et al.
Rheumatology (Oxford, England)|June 5, 2012
Antibodies to hnRNPs in patients with a systemic rheumatic disease with no antibodies to extractable nuclear antigens or dsDNAKatrijn Op De Beéck, Pieter Vermeersch, Patrick Verschueren, et al.
Autoimmunity Reviews|July 12, 2011
Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assayKatrijn Op De Beeck, Pieter Vermeersch, Patrick Verschueren, et al.
Annals of the Rheumatic Diseases|January 25, 2018
Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritisLieve Van Hoovels, Julie Jacobs, Bert Vander Cruyssen, et al.
Rheumatology Advances in Practice|February 22, 2020
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologistDiederik De Cock, Kristien Van der Elst, Veerle Stouten, et al.
Patient Education and Counseling|December 9, 2014
Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritisSabrina Meyfroidt, Kristien Van der Elst, Diederik De Cock, et al.
Pageof 16